Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice.

Area of Science:

• Genetics
• Pharmacology
• Clinical Diagnostics

Background:

• Pharmacogenomics (PGx) research investigates how genetic variations influence drug responses.
• Clinical adoption of pharmacogenetic testing is increasing across healthcare centers.
• Next-generation sequencing (NGS) presents a powerful tool for advancing PGx applications.

Purpose of the Study:

• To review the key considerations for integrating NGS technologies into clinical practice for pharmacogenetic testing.
• To evaluate the advantages and challenges associated with implementing NGS-based PGx solutions.
• To identify limitations of current NGS platforms and propose strategies for their clinical setup and management.

Main Methods:

• Literature review of current pharmacogenomics studies and clinical implementation strategies.
• Analysis of Next-generation sequencing technologies relevant to pharmacogenetic applications.
• Discussion of practical aspects including platform limitations, setup, and management.

Main Results:

• NGS offers a comprehensive, time-, and cost-effective method for pharmacogenetic analysis.
• Successful clinical implementation requires addressing specific challenges and limitations of NGS platforms.
• Strategies for setup and management are crucial for the effective use of NGS in guiding drug treatment.

Conclusions:

• NGS technologies are pivotal for the future of clinical pharmacogenomics.
• Careful consideration of advantages, challenges, and platform specifics is necessary for successful implementation.
• This review provides a framework for leveraging NGS to optimize drug therapy through personalized medicine.